Report Overview

Global leukapheresis market was worth USD 51.6 billion in 2020, and is further projected to reach USD 87.5 billion by 2027, at a CAGR of 7.8% during 2021-2027 (forecast period).

Global Leukapheresis Market Share, Industry Trends & Forecast Report 2027

Global leukapheresis market was worth USD 51.6 billion in 2020, and is further projected to reach USD 87.5 billion by 2027, at a CAGR of 7.8% during 2021-2027 (forecast period). The leukapheresis procedures are performed to determine the cause of a decline in white blood cell counts Increasing incidence and prevalence of leukemia disease, demand for leukopaks for research applications, and an increase in blood donations are some of the factors driving the market demand. Furthermore, pharmaceutical and biopharmaceutical companies have been growing their investment in medical research and development, which contributes to the overall market growth.

Source: BlueWeave Consulting

Global Leukapheresis Overview

Leukapheresis is a medical procedure that separates white blood cells (leukocytes) involved in the body's immune response from a blood sample. It is a type of apheresis in which a component of blood is extracted while the remaining blood is returned to circulation. Leukapheresis is often used to decrease very high white blood cell (WBC) counts such as can occur with chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be used to collect white blood cells for later transplant, such as to treat sharp declines in WBC counts caused by cancer chemotherapy.

Global Leukapheresis Market Trend

Growth Drivers

Rising Cases and Prevalence of Leukemia

Leukemia is a type of blood cell cancer. Blood cells are classified into three types: red blood cells (RBCs), white blood cells (WBCs), and platelets. Leukemia, in general, refers to cancers of the white blood cells. The rising incidence and prevalence of leukemia have risen significantly because of the genetic history of leukemia (inherited) and excessive smoking by pregnant women, which infects their blood and weakens their immune system. In 2020, the American Cancer Society estimated that there are 60,530 leukemia cases in the United States, owing to which the number of therapeutic leukapheresis procedures is increasing, thereby boosting the growth for the global leukapheresis market. Consumption of leukopaks has risen dramatically due to an increase in leukemia cases worldwide. Furthermore, since leukopaks are generated from normal peripheral blood and are transfused into infected bodies, the increased use of leukopaks fuels the growth of the global leukapheresis industry.

Rise of Leukapheresis in Pediatric Patients

According to the Leukemia & Lymphoma Community, 7.2 children per 100,000 are at risk of developing leukemia. The Federal Food, Drug, and Cosmetic Act (FD&C Act) define pediatric patients as persons aged 21 or younger at the time of their diagnosis or treatment. Doctors predict that one of the causes of childhood leukemia is that the mother was exposed to high levels of radiation or smoked excessively during her pregnancy, which resulted in the child developing leukemia. The scarcity of hospitals in both developed and developing countries that have specialist doctors for leukapheresis care for children drives market development. Furthermore, to counteract this problem, many government programs are being implemented to make leukemia care available at government hospitals, which is fueling the market growth.

Restraints

The High cost of Leukapheresis Products and Leukemia Treatment

Because of the high cost of care, the mortality rate from leukemia is increasing. People with leukemia often do not receive adequate treatment, which is a significant factor limiting the global leukapheresis market's growth. To battle leukemia, patients are required to consume leukapheresis products. The cost of these items is high, and most people cannot afford them, limiting the market growth. Furthermore, the leukapheresis treatment method and its components, leukopaks, are in very early stages of development. Blood cancer, also known as leukemia, is a deadly disease. The World Health Organization estimates that blood cancer could kill about 10 million people by 2020.

Impact of COVID-19

The COVID-19 pandemic has severely affected the global economy besides affecting business operations. Due to the high infection rates and adverse impact on public health systems, various countries had to enforce nationwide lockdowns which had a major impact on industrial supply chains, trade, and related services. The treatment of leukapheresis entails a large amount of blood transmission. As a result, people are afraid and are not getting proper treatment because they are afraid of being infected with COVID-19. Moreover, millions of enterprises face an existential threat. Informal economy employees are especially vulnerable because the majority lack social security, access to quality health care, and productive assets. Almost half of the world's 3.3 billion population is at the risk of losing their jobs.

Global Leukapheresis Market: By Applications

Based on application, the global leukapheresis market is grouped into research applications and therapeutic applications. In 2020, the research applications segment accounted for the largest share in the leukapheresis market. Immunology is becoming more widely used in cancer treatment, allowing patients to heal more quickly. In addition to that, infectious diseases, drug discovery, regenerative medicine, and cell-based therapies all contribute to the expansion of the leukapheresis industry. Cell-based therapies are the most commonly used means of treating deadly diseases such as cancer. Transplantation of hematopoietic stem cells is used for generating bone marrow; this type of innovation contributes to the global leukapheresis market's growth.

Source: BlueWeave Consulting

Global Leukapheresis Market: By Product

Based on product types, the global leukapheresis market is fragmented into devices, filters, columns, and disposables. The device segment held the largest share in the market in 2020 and is expected to maintain its dominance during the forecast period. This growth can be attributed to the increasing installation of centrifugal apheresis devices in hospitals, which are used in therapeutic leukapheresis procedures conducted to treat leukemia. Various blood donation centers and hospitals having facilities to treat leukemia patients are the major consumers of centrifugal apheresis. These are a few factors propelling the growth of the global leukapheresis market.

Global Leukapheresis Market: Regional Insights

Geographically, the global leukapheresis market is categorized into North America, Europe, the Asia-Pacific, the Middle East & Africa, and Latin America. The Asia-Pacific leads the global leukapheresis market and is projected to lead the overall market during the forecast period. The region's aging population is contributing to an increase in the incidence of leukemia. At the same time, improving healthcare infrastructure, which is accompanied by an increase in the number of clinical trials, especially in China, drives the market even further. Furthermore, the increasing public and private investments for the development of CAR-T cell therapy have increased the demand for leukapheresis testing services and the market in the region.

Competitive Landscape

The global leukapheresis market's high growth potential has attracted a slew of new entrants, resulting in numerous lucrative opportunities. The emergence of new entrants has also resulted in healthier competition among long-established service providers. Companies such as Haemonetics Corporation and Charles River Laboratories are investing in and securing lucrative contracts that will enable humanity to have access to cutting-edge technology in the future.

Some of the key players in the global leukapheresis market are Terumo BCT Inc., Lonza Group AG, Puri Blood Medical Co. Ltd, Beijing ZKSK Technology Co. Ltd, Guangzhou Daji Medical Science and Technology Co. Ltd, Miltenyi Biotec, Charles River Laboratories, Caltag Medsystems limited, Macopharma, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd, Stem Express, LLC, and other prominent players. In order to improve their production capability, product portfolio, and provide competitive differentiation, companies are increasingly participating in acquisitions, alliances, and mergers.

Recent Developments

• In March 2021, Charles River Laboratories International, Inc., acquired Retrogenix Limited—an early-stage contract research organization (CRO) providing specialized bioanalytical services utilizing its proprietary cell microarray technology.

• In January 2021, Haemonetics Corporation announced the signing of a definitive agreement to acquire privately-owned Cardiva Medical, Inc. Cardiva will be acquired by Haemonetics for an initial cash payment of USD 475 million.

Scope of the Report:

Attribute	Details
Years Considered	Historical data – 2017-2020
	Base Year – 2020
	Forecast – 2021 – 2027
Facts Covered	Revenue in USD Billion
Market Coverage	U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Japan, South Korea, China, India, UAE, South Africa, Saudi Arabia
Product/Service Segmentation	By product type, applications, indication, end-user, and region
Key Players	Key Players for the market are Terumo BCT Inc., Lonza Group AG, Puri Blood Medical Co. Ltd, Beijing ZKSK Technology Co. Ltd, Guangzhou Daji Medical Science and Technology Co. Ltd, Miltenyi Biotec, Charles River Laboratories, Caltag medsystems Limited, Macopharma, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd, Stem Express, LLC Other Prominent Players

 

By Product Type

• Devices

• Filters

• Columns

• Disposables

By Applications

• Research Applications

• Therapeutic Applications

By Indication

• ALL

• NHL

• Multiple Myeloma

By End User

• Hospitals & Clinics

• Pharmaceutical & Biotechnology Companies

• Academic & Research Institutes

• CRO

• Others

By Region

• The Asia-Pacific

• North America

• Europe

• Middle East & Africa

• Latin America

 

1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Research

2.2. Quantitative Research

2.3. Market Breakdown & Data Triangulation

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Region

2.5. Assumption & Limitation

3.    Executive Summary

4.    Global Leukapheresis Market Insights

4.1. Industry Value Chain Analysis

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Recent Development

4.4. Government Regulations

4.5. Porter’s Five Forces Analysis

4.5.1.   Bargaining Power of Suppliers

4.5.2.   Bargaining Power of Buyers

4.5.3.   Threat of New Entrants

4.5.4.   Threat of Substitutes

4.5.5.   Intensity of Rivalry

5.    Global Leukapheresis Market Overview

5.1. Market Size & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast

5.2.1.   By Product Type

5.2.1.1.       Devices

5.2.1.2.       Filters

5.2.1.3.       Columns

5.2.1.4.       Disposables

5.2.2.   By Applications

5.2.2.1.       Research Applications

5.2.2.2.       Therapeutic Applications

5.2.3.   By Indication

5.2.3.1.       ALL (Acute Lymphocytic Leukemia)

5.2.3.2.       NHL (Non-Hodgkin’s Lymphoma)

5.2.3.3.       Multiple Myeloma

5.2.4.   By End User

5.2.4.1.       Hospitals & Clinics

5.2.4.2.       Pharmaceutical & Biotechnology Companies

5.2.4.3.       Academic & Research Institutes 

5.2.4.4.       CRO

5.2.4.5.       Others

5.2.5.   By Region

5.2.5.1.     North America

5.2.5.2.     Europe

5.2.5.3.     Asia Pacific

5.2.5.4.     Latin America

5.2.5.5.     Middle East and Africa

6.    North America Leukapheresis Market  

6.1. Market Size & Forecast by Value, 2017-2027

6.1.1.   By Value (USD Million)

6.2. Market Share & Forecast

6.2.1.   By Product Type

6.2.2.   By Applications

6.2.3.   By Indication

6.2.4.   By End-Users

6.2.5.   By Country

6.2.5.1.     United States

6.2.5.2.     Canada

7.    Europe Leukapheresis Market

7.1. Market Size & Forecast by Value, 2017-2027

7.1.1.   By Value (USD Million)

7.2. Market Share & Forecast

7.2.1.   By Product Type

7.2.2.   By Applications

7.2.3.   By Indication

7.2.4.   By End-Users

7.2.5.   By Country

7.2.5.1.     Germany

7.2.5.2.     United Kingdom

7.2.5.3.     Italy

7.2.5.4.     France

7.2.5.5.     Spain

7.2.5.6.     Rest of Europe

8.    Asia Pacific Leukapheresis Market

8.1. Market Size & Forecast by Value, 2017-2027

8.1.1.   By Value (USD Million)

8.2. Market Share & Forecast

8.2.1.   By Product Type

8.2.2.   By Applications

8.2.3.   By Indication

8.2.4.   By End-Users

8.2.5.   By Country

8.2.5.1.     China

8.2.5.2.     India

8.2.5.3.     Japan

8.2.5.4.     Australia

8.2.5.5.     South Korea

8.2.5.6.     Rest of Asia Pacific

9.    Latin America Leukapheresis Market

9.1.  Market Size & Forecast by Value, 2017-2027

9.1.1.       By Value (USD Million)

9.2. Market Share & Forecast

9.2.1.       By Product Type

9.2.2.       By Applications

9.2.3.       By Indication

9.2.4.       By End-Users

9.2.5.       By Country

9.2.5.1.     Brazil

9.2.5.2.     Mexico

9.2.5.3.     Argentina

9.2.5.4.     Rest of Latin America

10.Middle East & Africa Leukapheresis Market

10.1. Market Size & Forecast by Value, 2017-2027

10.1.1.  By Value (USD Million)

10.2. Market Share & Forecast

10.2.1.    By Product Type

10.2.2.    By Applications

10.2.3.    By Indication

10.2.4.    By End-Users

10.2.5.    By Country

10.2.5.1.  Saudi Arabia

10.2.5.2.  Turkey

10.2.5.3.  UAE

10.2.5.4.  South Africa

10.2.5.5.  Rest of Middle East & Africa

11.Competitive Landscape

11.1.          List of Key Players and Their Offerings

11.2.          Market Share Analysis, 2020

11.3.          Competitive Benchmarking, By Operating Parameters

12.Impact of Covid-19 on Leukapheresis Market Industry

13.Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **

13.1.        Terumo BCT Inc.

13.2.        Lonza Group AG

13.3.        Puri Blood Medical Co. Ltd

13.4.        Beijing ZKSK Technology Co. Ltd

13.5.        Guangzhou Daji Medical Science and Technology Co. Ltd

13.6.        Miltenyi Biotec

13.7.        Charles River Laboratories

13.8.        Caltag medsystems Limited

13.9.        Macopharma, Haemonetics Corporation

13.10.     Asahi Kasei Medical Co. Ltd

13.11.     Stem Express

13.12.     Other Prominent Players

14.Key Strategic Recommendations

 

List of Figures

 

Fig: Global Leukapheresis Segmentation

Fig: Global Leukapheresis Market Value Chain Analysis

Fig: Company Market Share Analysis, 2020

Fig: Global Leukapheresis Market Size, By Value (USD Million), 2017-2027

Fig: Global Leukapheresis Market Share, By Product Type, By Value, 2017-2027

Fig: Global Leukapheresis Market Share, By Applications, By Value, 2017-2027

Fig: Global Leukapheresis Market Share, By Indication, By Value, 2017-2027

Fig: Global Leukapheresis Market Share, By End-Users, By Value, 2017-2027

Fig: Global Leukapheresis Market Share, By Region, By Value, 2017-2027

Fig: North America Leukapheresis Market Size, By Value (USD Million), 2017-2027

Fig: North America Leukapheresis Market Share, By Product Type, By Value, 2017-2027

Fig: North America Leukapheresis Market Share, By Applications, By Value, 2017-2027

Fig: North America Leukapheresis Market Share, By End-Users, By Value, 2017-2027

Fig: North America Leukapheresis Market Share, By Country, By Value, 2017-2027

Fig: Europe Leukapheresis Market Size, By Value (USD Million), 2017-2027

Fig: Europe Leukapheresis Market Share, By Product Type, By Value, 2017-2027

Fig: Europe Leukapheresis Market Share, By Applications, By Value, 2017-2027

Fig: Europe Leukapheresis Market Share, By Indication, By Value, 2017-2027

Fig: Europe Leukapheresis Market Share, By End-Users, By Value, 2017-2027

Fig: Europe Leukapheresis Market Share, By Country, By Value, 2017-2027

Fig: Asia-Pacific Leukapheresis Market Size, By Value (USD Million), 2017-2027

Fig: Asia-Pacific Leukapheresis Market Share, By Product Type, By Value, 2017-2027

Fig: Asia-Pacific Leukapheresis Market Share, By Applications, By Value, 2017-2027

Fig: Asia-Pacific Leukapheresis Market Share, By Indication, By Value, 2017-2027

Fig: Asia-Pacific Leukapheresis Market Share, By End-Users, By Value, 2017-2027

Fig: Asia-Pacific Leukapheresis Market Share, By Country, By Value, 2017-2027

Fig: Latin America Leukapheresis Market Size, By Value (USD Million), 2017-2027

Fig: Latin America Leukapheresis Market Share, By Product Type, By Value, 2017-2027

Fig: Latin America Leukapheresis Market Share, By Applications, By Value, 2017-2027

Fig: Latin America Leukapheresis Market Share, By Indication, By Value, 2017-2027

Fig: Latin America Leukapheresis Market Share, By End-Users, By Value, 2017-2027

Fig: Latin America Leukapheresis Market Share, By Country, By Value, 2017-2027

Fig: Middle East & Africa Leukapheresis Market Size, By Value (USD Million), 2017-2027

Fig: Middle East & Africa Leukapheresis Market Share, By Product Type, By Value, 2017-2027

Fig: Middle East & Africa Leukapheresis Market Share, By Applications, By Value, 2017-2027

Fig: Middle East & Africa Leukapheresis Market Share, By Indication, By Value, 2017-2027

Fig: Middle East & Africa Leukapheresis Market Share, By End-Users, By Value, 2017-2027

Fig: Middle East & Africa Leukapheresis Market Share, By Country, By Value, 2017-2027

 

List of Table

Table: Global Leukapheresis Market Size, By Product Type, By Value, 2017-2027

Table: Global Leukapheresis Market Size, By Applications, By Value, 2017-2027

Table: Global Leukapheresis Market Size, By Indication, By Value, 2017-2027

Table: Global Leukapheresis Market Size, By End-Users, By Value, 2017-2027

Table: Global Leukapheresis Market Size, By Region, By Value, 2017-2027

Table: North America Leukapheresis Market Size, By Product Type, By Value, 2017-2027

Table: North America Leukapheresis Market Size, By Applications, By Value, 2017-2027

Table: North America Leukapheresis Market Size, By Indication, By Value, 2017-2027

Table: North America Leukapheresis Market Size, By End-Users, By Value, 2017-2027

Table: North America Leukapheresis Market Size, By Country, By Value, 2017-2027

Table: Europe Leukapheresis Market Size, By Product Type, By Value, 2017-2027

Table: Europe Leukapheresis Market Size, By Applications, By Value, 2017-2027

Table: Europe Leukapheresis Market Size, By Indication, By Value, 2017-2027

Table: Europe Leukapheresis Market Size, By End-Users, By Value, 2017-2027

Table: Europe Leukapheresis Market Size, By Country, By Value, 2017-2027

Table: Asia-Pacific Leukapheresis Market Size, By Product Type, By Value, 2017-2027

Table: Asia-Pacific Leukapheresis Market Size, By Applications, By Value, 2017-2027

Table: Asia-Pacific Leukapheresis Market Size, By Indication, By Value, 2017-2027

Table: Asia-Pacific Leukapheresis Market Size, By End-Users, By Value, 2017-2027

Table: Asia-Pacific Leukapheresis Market Size, By Country, By Value, 2017-2027

Table: Latin America Leukapheresis Market Size, By Product Type, By Value, 2017-2027

Table: Latin America Leukapheresis Market Size, By Applications, By Value, 2017-2027

Table: Latin America Leukapheresis Market Size, By Indication, By Value, 2017-2027

Table: Latin America Leukapheresis Market Size, By End-Users, By Value, 2017-2027

Table: Latin America Leukapheresis Market Size, By Country, By Value, 2017-2027

Table: Middle East & Africa Leukapheresis Market Size, By Product Type, By Value, 2017-2027

Table: Middle East & Africa Leukapheresis Market Size, By Applications, By Value, 2017-2027

Table: Middle East & Africa Leukapheresis Market Size, By Indication, By Value, 2017-2027

Table: Middle East & Africa Leukapheresis Market Size, By End-Users, By Value, 2017-2027

Table: Middle East & Africa Leukapheresis Market Size, By Country, By Value, 2017-2027

Table: Terumo BCT Inc Financial Analysis

Table: Lonza Group AG Financial Analysis

Table: Puri Blood Medical Co. Ltd Financial Analysis

Table: Beijing ZKSK Technology Co. Ltd Financial Analysis

Table: Guangzhou Daji Medical Science and Technology Co. Ltd Financial Analysis

Table: Miltenyi Biotec Financial Analysis

Table: Charles River Laboratories Financial Analysis

Table: Caltag Medsystems Limited Financial Analysis

Table: Macopharma Financial Analysis

Table: Haemonetics Corporation Industries Financial Analysis

Table: Asahi Kasei Medical Co. Ltd Financial Analysis

Table: Stem Express Financial Analysis